LEIDY CARABALLO GALVA

Concepts (20)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
2
2021
930
0.770
Why?
Liver Neoplasms
2
2021
1314
0.690
Why?
Immunotherapy
1
2020
680
0.470
Why?
Immunotherapy, Adoptive
1
2020
833
0.420
Why?
Glypicans
1
2021
39
0.190
Why?
T-Lymphocytes
2
2020
1725
0.180
Why?
alpha-Fetoproteins
1
2020
132
0.160
Why?
Xenograft Model Antitumor Assays
1
2021
889
0.150
Why?
Cancer Vaccines
1
2020
177
0.150
Why?
Receptors, Antigen, T-Cell
1
2020
483
0.130
Why?
Antibodies, Monoclonal
1
2021
1035
0.120
Why?
Mice
2
2021
17637
0.070
Why?
Animals
2
2021
34238
0.050
Why?
Humans
3
2021
125195
0.040
Why?
HLA-A2 Antigen
1
2020
26
0.040
Why?
Pyrophosphatases
1
2020
21
0.040
Why?
Phosphoric Diester Hydrolases
1
2020
65
0.040
Why?
Cross Reactions
1
2020
192
0.040
Why?
Lymphocyte Activation
1
2020
701
0.040
Why?
Cells, Cultured
1
2020
3056
0.030
Why?
CARABALLO GALVA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (20)
Explore
_
Similar People (60)
Explore
_